Amundi Has $750,000 Stock Position in Ingevity Co. (NYSE:NGVT)

Amundi boosted its stake in Ingevity Co. (NYSE:NGVT) by 193.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,876 shares of the company’s stock after buying an additional 13,097 shares during the period. Amundi owned approximately 0.05% of Ingevity worth $750,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vestcor Inc acquired a new position in Ingevity in the 3rd quarter valued at about $796,000. Geode Capital Management LLC grew its stake in Ingevity by 4.3% in the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company’s stock valued at $31,817,000 after buying an additional 33,973 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Ingevity by 24.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 117,581 shares of the company’s stock valued at $4,586,000 after buying an additional 23,460 shares during the last quarter. Hennion & Walsh Asset Management Inc. acquired a new position in Ingevity in the 4th quarter valued at about $239,000. Finally, Proficio Capital Partners LLC acquired a new stake in Ingevity in the 4th quarter worth about $863,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

NGVT has been the subject of several analyst reports. StockNews.com upgraded shares of Ingevity from a “hold” rating to a “buy” rating in a research note on Thursday, February 20th. BMO Capital Markets upgraded shares of Ingevity from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $62.00 to $65.00 in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $55.17.

Ingevity Stock Up 0.8 %

Shares of NYSE NGVT opened at $44.25 on Thursday. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -3.74 and a beta of 1.53. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.30. The stock has a 50-day moving average price of $45.09 and a two-hundred day moving average price of $42.25.

Ingevity (NYSE:NGVT) last issued its earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.29 by $0.66. The firm had revenue of $298.80 million during the quarter, compared to the consensus estimate of $297.40 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. As a group, analysts forecast that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.